Investing.com - Adial Pharma (NASDAQ: ADIL) reported first quarter EPS of $-0.150, in line with the analyst estimate of $-0.150. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Adial Pharma's stock price closed at $0.360. It is up 0% in the last 3 months and down -82.410% in the last 12 months.
Adial Pharma saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Adial Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Adial Pharma's Financial Health score is "weak performance".
Check out Adial Pharma's recent earnings performance, and Adial Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar